1.ERG b/a ratio and retinal circulation time of CRVO.
Ha Kyoung KIM ; Won Oh SON ; Kyoo Ryong CHOI
Korean Journal of Ophthalmology 1988;2(1):9-12
Fourteen cases of central retinal vein occlusion (CRVO) were studied with electroretinogram (ERG) and fluorescein angiogram. The cases were divided into a venous stasis retinopathy group (VSR,9 cases) and a hemorrhagic retinopathy group(HR, 5 cases). The b/a ratio and retinal circualtion time (RCT) were measured and compared with the control group. The mean b/a ratio of the HR group (0.86) was decreased as compared with the VSR group (1.18) and the control group (1.23). The RCT of the HR group was markedly delayed to 13.68 seconds as compared with the VSR group (11.09 sec) and the control group (6.4 sec). These facts suggest that both the b/a ratio and the RCT are possible parameters for estimating retinal ischemia and that the ERG is a reliable examination method for classification of CRVO.
Adult
;
*Electroretinography
;
Female
;
Fluorescein Angiography
;
Humans
;
Male
;
Middle Aged
;
Retinal Vein Occlusion/diagnosis/*physiopathology
;
Retinal Vessels/*physiopathology
;
Time Factors
2.Neovascular Glaucoma Due to Branch Retinal Vein Occlusion Combined with Branch Retinal Artery Occlusion.
Korean Journal of Ophthalmology 2013;27(1):64-67
Branch retinal artery occlusion (BRAO) and branch retinal vein occlusion (BRVO) rarely cause neovascular glaucoma (NVG). A 58-year-old woman with hypertension and type 2 diabetic mellitus complained of progressive visual loss in her right eye for the previous 3 months. At initial examination, visual acuity was 20 / 63 in the right eye. Angle neovascularization was observed and the intraocular pressure (IOP) was 30 mmHg in her right eye. Fundus examination and fluorescein angiography showed BRAO combined with BRVO. We immediately injected intravitreal and intracameral bevacizumab in her right eye. The next day, we performed scatter photocoagulation in the nonperfusion area. One month later, visual acuity was 20 / 20 in her right eye and the IOP was 17 mmHg with one topical antiglaucoma agent. The neovascularization had regressed completely. We report a case of unilateral NVG which was caused by BRAO with concomitant BRVO and advise close ophthalmic examination of the iris and angle in BRVO with BRAO.
Diagnosis, Differential
;
Female
;
Fluorescein Angiography
;
Fundus Oculi
;
Glaucoma, Neovascular/diagnosis/*etiology/physiopathology
;
Humans
;
Intraocular Pressure
;
Middle Aged
;
Retinal Artery Occlusion/*complications/diagnosis
;
Retinal Vein Occlusion/*complications/diagnosis
3.Collateral vessels in branch retinal vein occlusion.
Chan Young IM ; Soo Young LEE ; Oh Woong KWON
Korean Journal of Ophthalmology 2002;16(2):82-87
Experiments show that collaterals that develop and maturate in branch retinal vein occlusion (BRVO) are helpful in the drainage of blood from a blocked area to an adjacent area. Laser treatment on the nonperfusion area can reduce the retinal blood inflow that can impair the formation of collateral vessels. Furthermore, if collaterals were accidentally destroyed by laser photocoagulation, leakage and neovascularization would increase. Forty-five patients with BRVO were reviewed retrospectively. Collateral vessels were noted from angiographic analysis in 27 of 45 (60%) patients. Good visual prognosis was noted in the patients with collaterals. Cases with neovascularization underwent laser treatment. In one case, laser photocoagulation was applied to the collateral vessels accidentally, after which the leakage significantly increased on fluorescein angiography. In conclusion, collateral vessels in BRVO have a favorable effect on visual prognosis. Careful laser treatment is recommended to avoid destroying collaterals in BRVO.
Aged
;
Aged, 80 and over
;
Collateral Circulation
;
Female
;
Fluorescein Angiography
;
Human
;
Male
;
Middle Aged
;
Prognosis
;
Retinal Neovascularization/diagnosis/*physiopathology
;
Retinal Vein Occlusion/diagnosis/*physiopathology
;
Retrospective Studies
;
Visual Acuity
4.Neovascularization in Branch Retinal Vein Occlusion Combined with Arterial Insufficiency.
Yoon Jung LEE ; Joon Hyun KIM ; Myung Kyoo KO
Korean Journal of Ophthalmology 2005;19(1):34-39
The aim of this study is to elucidate the association of neovascularization in branch retinal vein occlusion (BRVO) combined with major arterial insufficiency (MAI), compared with BRVO alone. The authors retrospectively reviewed the charts, color photographs, and fluorescein angiograms of 304 patients (308 eyes) who had BRVO from 1990 to 2002 at Hanyang University hospital. Patients with BRVO combined with MAI and patients with BRVO alone were differentiated by angiographic appearance. Of the 308 eyes, 12 (3.9%) had neovascularization, all of which were in the 56 eyes of the MAI group for which the neovascularization rate was 21.4%. Neovascularization in BRVO was more strongly associated with the non-perfusion caused by MAI, rather than with the extent of the non-perfusion area that originated from retinal capillary obstruction. MAI is considered as a risk factor for neovascularization and hence could be a prognostic factor.
Adult
;
Aged
;
Comparative Study
;
Female
;
Fluorescein Angiography
;
Humans
;
Male
;
Middle Aged
;
Retinal Artery/*physiopathology
;
Retinal Diseases/*complications/physiopathology
;
Retinal Neovascularization/diagnosis/*etiology/physiopathology
;
Retinal Vein Occlusion/*complications/diagnosis/physiopathology
;
Retrospective Studies
6.Patient's Self-recognition of Reduced Visual Acuity Due to Recurrence of Macular Edema and Prompt Visitation to the Hospital in Retinal Vein Occlusion.
Seong Hun JEONG ; Jae Hui KIM ; Jong Woo KIM ; Tae Gon LEE ; Chul Gu KIM ; Su Jin YOO ; Mun Jung CHOI
Korean Journal of Ophthalmology 2014;28(3):213-219
PURPOSE: To evaluate patients' self-recognition of reduced visual acuity due to recurring macular edema in retinal vein occlusion. METHODS: A retrospective review of medical records of patients who were diagnosed with recurring macular edema secondary to retinal vein occlusion was performed. The proportion of patients who recognized reduced visual acuity due to the recurrence of macular edema and who visited the hospital before the scheduled follow-up date was determined. Parameters including age, sex, diagnosis, visual acuity before recurrence of macular edema, and extent of visual acuity reduction due to recurrence of macular edema were compared in patients who recognized a reduction in visual acuity and those who did not. The proportion of patients who visited the hospital promptly was also determined. RESULTS: Forty eyes of 40 patients were included in the analysis. Sixteen and 24 patients were diagnosed with central retinal vein occlusion and branch retinal vein occlusion, respectively. Twenty-one patients (52.5%) recognized reduced visual acuity due to recurring macular edema. These patients were younger (59.2 +/- 7.6 vs. 64.8 +/- 9.4 years, p = 0.046), had better visual acuity before recurrence of macular edema (0.52 +/- 0.48 vs. 1.02 +/- 0.46, p = 0.002), and exhibited a greater reduction in visual acuity after recurrence of macular edema (0.34 +/- 0.24 vs. 0.14 +/- 0.13, p = 0.003). Only four patients visited the hospital before the scheduled follow-up date, and all of these patients lived relatively close to the hospital. CONCLUSIONS: For prompt treatment of recurring macular edema, more intensive education about the self-estimation of visual acuity is necessary, particularly for elderly patients who have relatively poor visual acuity. In addition, a simple and easy way to identify the recurrence of macular edema at the local clinic should be established for patients who live relatively far from the hospital.
Female
;
Fluorescein Angiography
;
Follow-Up Studies
;
Fundus Oculi
;
Humans
;
Macular Edema/*diagnosis/etiology/physiopathology
;
Male
;
Middle Aged
;
*Patient Readmission
;
Recurrence
;
Retinal Vein Occlusion/*complications/diagnosis/physiopathology
;
Retrospective Studies
;
Tomography, Optical Coherence
;
*Visual Acuity
7.Progression of Impending Central Retinal Vein Occlusion to the Ischemic Variant Following Intravitreal Bevacizumab.
Korean Journal of Ophthalmology 2010;24(3):179-181
A 60-year-old woman who had experienced two episodes of amaurosis fugax in her right eye presented with vision loss. Two weeks earlier, at a private clinic, she was diagnosed with impending central retinal vein occlusion (CRVO) of the right eye and received an intravitreal injection of bevacizumab. Two weeks after this injection she was diagnosed with ischemic CRVO. At 11-weeks post-presentation, extremely ischemic features were observed with fluorescein angiographic findings of severe vascular attenuation and extensive retinal capillary obliteration. At 22-weeks post-presentation she was diagnosed with neovascular glaucoma; she experienced no visual improvement over the following several months.
Antibodies, Monoclonal/*administration & dosage
;
Disease Progression
;
Female
;
Fluorescein Angiography
;
Glaucoma, Neovascular/complications
;
Humans
;
Injections, Intraocular
;
Ischemia/diagnosis/*etiology/physiopathology
;
Middle Aged
;
Retinal Vein Occlusion/*complications/*drug therapy/physiopathology
;
*Retinal Vessels
;
Vascular Endothelial Growth Factor A/antagonists & inhibitors
;
Visual Acuity/drug effects
;
Vitreous Body